|
Real-time Estimate
Cboe BZX
04:44:59 30/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 41.91 USD | -1.23% |
|
-8.45% | -55.83% |
| 02:32am | UBS Adjusts Boston Scientific Price Target to $57 From $67, Maintains Buy Rating | MT |
| 02:09am | Mizuho Securities Adjusts Boston Scientific Price Target to $50 From $55 | MT |
| Market Cap | 61.49B 55.08B 50.81B 45.98B 85.98B 5,856B 87.37B 606B 242B 3,065B 231B 226B 9,706B | P/E 2026 * |
17x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 70.72B 63.34B 58.44B 52.88B 98.88B 6,734B 100B 697B 278B 3,524B 265B 260B 11,162B | EV / Sales 2026 * |
3.37x | EV / Sales 2027 * | 3.12x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Tradegate
| BSX | Real-time | |
|
London S.E.
| 0HOY | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Xetra
| BSX | Delayed | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Boston Scientific Corporation
| 1 day | -1.12% | ||
| 1 week | -8.45% | ||
| Current month | -3.51% | ||
| 1 month | -4.01% | ||
| 3 months | -8.51% | ||
| 6 months | -26.30% | ||
| Current year | -55.83% |
| 1 week | 39.57 |  | 46.16 |
| 1 month | 39.57 | | 46.16 |
| Current year | 39.57 | | 100.9 |
| 1 year | 39.57 | | 105.65 |
| 3 years | 39.57 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/8/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/8/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/8/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.19% | -8.45% | -58.01% | -15.84% | 61.49B | |
| +0.23% | +4.59% | +26.74% | +62.99% | 260B | |
| +0.67% | +2.70% | +10.26% | +27.48% | 165B | |
| +0.74% | +1.05% | -16.57% | +73.51% | 154B | |
| +2.60% | +5.03% | +14.43% | +51.74% | 52.9B | |
| +0.70% | +2.71% | -13.09% | -6.29% | 52.84B | |
| -1.84% | -3.37% | +8.73% | +63.81% | 51.46B | |
| -0.40% | +4.12% | +26.43% | +78.96% | 51.16B | |
| +0.30% | +5.40% | +39.81% | +102.87% | 46.85B | |
| +0.23% | +7.97% | +206.07% | +169.64% | 43.61B | |
| Average | +0.26% | +1.41% | +24.48% | +60.89% | 93.93B | |
| Weighted average by Cap. | +0.38% | +1.44% | +16.24% | +56.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.97B 18.78B 17.33B 15.68B 29.32B 1,997B 29.79B 207B 82.46B 1,045B 78.68B 77.01B 3,310B | 21.44B 19.21B 17.72B 16.03B 29.98B 2,042B 30.47B 211B 84.33B 1,069B 80.47B 78.76B 3,385B |
| Net income | 3.65B 3.27B 3.01B 2.73B 5.1B 347B 5.18B 35.96B 14.34B 182B 13.69B 13.4B 576B | 3.6B 3.23B 2.98B 2.69B 5.04B 343B 5.12B 35.52B 14.17B 180B 13.52B 13.23B 569B |
| Net Debt | 9.22B 8.26B 7.62B 6.9B 12.9B 878B 13.11B 90.95B 36.28B 460B 34.62B 33.88B 1,456B | 5.49B 4.92B 4.54B 4.11B 7.68B 523B 7.81B 54.17B 21.61B 274B 20.62B 20.18B 867B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | USD 42.16 | -0.65% | 16,503,968 |
| 28/10/26 | USD 42.43 | -5.84% | 69,837,060 |
| 27/10/26 | USD 45.06 | -1.14% | 15,139,721 |
| 26/10/26 | USD 45.58 | -0.24% | 11,928,715 |
| 23/10/26 | USD 45.69 | -0.70% | 8,772,772 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
